Showing results (971-980 of 1,037) with videos related to

Sort By:
Pageof 104
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 5, 2025
Inverse Regulation of TLR4 and PD-L1 Shapes the Inflammatory Tumor Microenvironment in Oral Squamous Cell CarcinomasCamila Alves Ferri, Giuseppe Pannone, Maria Carmela Pedicillo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2026
Prognostic significance of lymphovascular space invasion extent across molecular classes in early-stage endometrial cancer: A large retrospective analysisIlaria Capasso, Emanuele Perrone, Rossella Letizia Mancusi, et al.
The American Journal of Surgical Pathology|February 3, 2021
A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor): A Report of 22 CasesJennifer A Bennett, Robert H Young, Brooke E Howitt, et al.
JCO Oncology Practice|November 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian CancerClaudia Marchetti, Gwenael Ferron, Olivier Colomban, et al.
Nature|December 12, 2024
Io's tidal response precludes a shallow magma oceanR S Park, R A Jacobson, L Gomez Casajus, et al.
Cancers|April 12, 2022
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer PatientsCrescenzo D'Alterio, Anna Spina, Laura Arenare, et al.
Swiss Medical Weekly|January 29, 2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study dataHelena Aebersold, Fabienne Foster-Witassek, Sina Amberg, et al.
Frontiers in Immunology|February 17, 2022
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still MattersSarah Parisi, Loredana Ruggeri, Elisa Dan, et al.
Cancer Medicine|March 31, 2023
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical studyGiovanni Marconi, Anna Candoni, Roberta Di Nicola, et al.
The Lancet. Oncology|July 13, 2016
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort studyMarina Bagnoli, Silvana Canevari, Daniela Califano, et al.
Pageof 104